BA
VIRX

Boston Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Boston Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-105
Closed -$114K – 593
2013
Q2 		$114K Buy
+105
New +$114K 0.01% 551